Tolerant B Lymphocytes Acquire Resistance to Fas-mediated Apoptosis After Treatment with Interleukin 4 but Not After Treatment with Specific Antigen Unless a Surface Immunoglobulin Threshold is Exceeded

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1998 Apr 4

PMID 9500787

Citations 8

Authors

L C Foote

A Marshak-Rothstein

T L Rothstein

Affiliations

Soon will be listed here.

Abstract

Susceptibility to Fas-mediated apoptosis in nontolerant B cells is regulated in a receptor-specific fashion. To explore the regulation of Fas killing in tolerant, autoreactive B cells, mice doubly transgenic for hen egg lysozyme (HEL)-specific B cell receptors and soluble HEL were examined. Engagement of CD40 led to enhanced Fas expression and acquisition of sensitivity to Fas-mediated apoptosis in tolerant B cells, similar to that observed in nontolerant, receptor transgenic B cells. Engagement of surface immunoglobulin by specific (HEL) antigen failed to induce Fas resistance in tolerant B cells, in contrast to its effect on nontolerant B cells; however, cross-linking of biotinylated HEL with streptavidin induced similar levels of Fas resistance in tolerant and nontolerant B cells, which approximated the degree of Fas resistance produced by anti-Ig. Unlike surface Ig (sIg) engagement, physiological engagement of IL-4 receptors produced similar levels of Fas resistance in tolerant and nontolerant B cells. Thus, tolerant B cells differ from nontolerant B cells in the diminished capacity of surface immunoglobulin engagement to produce Fas resistance; however, tolerant B cells can be induced to become resistant to Fas-mediated apoptosis by IL-4 or by higher order cross-linking of sIg receptors.

Citing Articles

The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers.

Velapasamy S, Dawson C, Young L, Paterson I, Yap L Cancers (Basel). 2018; 10(8.

PMID: 30060514 PMC: 6115974. DOI: 10.3390/cancers10080247.

Expression analysis, single nucleotide polymorphisms and combined genotypes in candidate genes and their associations with growth and carcass traits in Qinchuan cattle.

Wang L, Liu X, Wang H, He H, Li Z, Chen L Mol Biol Rep. 2012; 40(3):2335-46.

PMID: 23196708 DOI: 10.1007/s11033-012-2315-3.

The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.

Koncz G, Hueber A Front Immunol. 2012; 3:207.

PMID: 22848207 PMC: 3404404. DOI: 10.3389/fimmu.2012.00207.

CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.

Ahmadi T, Flies A, Efebera Y, Sherr D Immunology. 2007; 124(1):129-40.

PMID: 18067555 PMC: 2434387. DOI: 10.1111/j.1365-2567.2007.02749.x.

B-cell anergy: from transgenic models to naturally occurring anergic B cells?.

Cambier J, Gauld S, Merrell K, Vilen B Nat Rev Immunol. 2007; 7(8):633-43.

PMID: 17641666 PMC: 3714009. DOI: 10.1038/nri2133.

References

Rothstein T, Wang J, Panka D, Foote L, Wang Z, Stanger B . Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature. 1995; 374(6518):163-5. DOI: 10.1038/374163a0. View

Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P . TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med. 1995; 181(2):781-6. PMC: 2191883. DOI: 10.1084/jem.181.2.781. View

Francis D, Karras J, Ke X, Sen R, Rothstein T . Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol. 1995; 7(2):151-61. DOI: 10.1093/intimm/7.2.151. View

Rathmell J, Cooke M, Ho W, Grein J, Townsend S, Davis M . CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature. 1995; 376(6536):181-4. DOI: 10.1038/376181a0. View

Prak E, Weigert M . Light chain replacement: a new model for antibody gene rearrangement. J Exp Med. 1995; 182(2):541-8. PMC: 2192124. DOI: 10.1084/jem.182.2.541. View

Garrone P, Neidhardt E, Garcia E, Galibert L, van Kooten C, Banchereau J . Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 1995; 182(5):1265-73. PMC: 2192208. DOI: 10.1084/jem.182.5.1265. View

Schattner E, Elkon K, Yoo D, Tumang J, Krammer P, Crow M . CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med. 1995; 182(5):1557-65. PMC: 2192191. DOI: 10.1084/jem.182.5.1557. View

DiPiro J, Howdieshell T, Goddard J, Callaway D, Hamilton R, MANSBERGER Jr A . Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg. 1995; 130(11):1159-62; discussion 1162-3. DOI: 10.1001/archsurg.1995.01430110017004. View

Goodnow C . Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A. 1996; 93(6):2264-71. PMC: 39784. DOI: 10.1073/pnas.93.6.2264. View

10.

Lagresle C, Mondiere P, Bella C, Krammer P, Defrance T . Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J Exp Med. 1996; 183(4):1377-88. PMC: 2192491. DOI: 10.1084/jem.183.4.1377. View

11.

Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J . Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci U S A. 1996; 93(5):2131-6. PMC: 39922. DOI: 10.1073/pnas.93.5.2131. View

12.

Foote L, Schneider T, Fischer G, Wang J, Rasmussen B, Campbell K . Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J Immunol. 1996; 157(5):1878-85. View

13.

Foote L, HOWARD R, Marshak-Rothstein A, Rothstein T . IL-4 induces Fas resistance in B cells. J Immunol. 1996; 157(7):2749-53. View

14.

Rathmell J, Townsend S, Xu J, Flavell R, Goodnow C . Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell. 1996; 87(2):319-29. DOI: 10.1016/s0092-8674(00)81349-5. View

15.

Schneider T, Grillot D, Foote L, Nunez G, Rothstein T . Bcl-x protects primary B cells against Fas-mediated apoptosis. J Immunol. 1997; 159(10):4834-9. View

16.

Izui S, Kelley V, Masuda K, Yoshida H, Roths J, MURPHY E . Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol. 1984; 133(1):227-33. View

17.

Atkinson P, Lampman G, Furie B, Naparstek Y, Schwartz R, Stollar B . Homology of the NH2-terminal amino acid sequences of the heavy and light chains of human monoclonal lupus autoantibodies containing the dominant 16/6 idiotype. J Clin Invest. 1985; 75(4):1138-43. PMC: 425437. DOI: 10.1172/JCI111808. View

18.

Carroll P, Stafford D, Schwartz R, Stollar B . Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J Immunol. 1985; 135(2):1086-90. View

19.

Brunswick M, Finkelman F, HIGHET P, INMAN J, Dintzis H, Mond J . Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol. 1988; 140(10):3364-72. View

20.

Goodnow C, Crosbie J, Adelstein S, Lavoie T, Brink R, Wotherspoon J . Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988; 334(6184):676-82. DOI: 10.1038/334676a0. View